Skip to content

Kush Parmar, Director at Entrada Therapeutics, sold TRDA on Aug 10, 2026

Data as of Oct 16

▼ SELL$647K92,444 shares at $7.00Kush Parmar DirectorTRDA Entrada Therapeutics, Inc.
Watch TRDA
Traded
Aug 10, 2026
Disclosed
Aug 10, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Kush Parmar, Director at Entrada Therapeutics, sold TRDA on Aug 10, 2026TRADEDDISCLOSED
TRDASimilar stocks (XLV — its sector index fund), rebased to TRDA's price on the disclosure day
TRDA since disclosure
−37.1%
after the sale
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund

Change in closing price from Aug 10, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLKush Parmar DirectorTRDA Entrada Therapeutics, Inc.$358Kdisclosed Aug 10 · filed 3 days after the trade
  2. ▼ SELLKush Parmar DirectorTRDA Entrada Therapeutics, Inc.$73.5Kdisclosed Aug 10 · filed 4 days after the trade

See every trade on TRDA →